These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1612008)

  • 1. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
    MacLaughlin DT; Hudson PL; Graciano AL; Kenneally MK; Ragin RC; Manganaro TF; Donahoe PK
    Endocrinology; 1992 Jul; 131(1):291-6. PubMed ID: 1612008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
    Wilson CA; di Clemente N; Ehrenfels C; Pepinsky RB; Josso N; Vigier B; Cate RL
    Mol Endocrinol; 1993 Feb; 7(2):247-57. PubMed ID: 8469238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
    Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
    Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.
    Masiakos PT; MacLaughlin DT; Maheswaran S; Teixeira J; Fuller AF; Shah PC; Kehas DJ; Kenneally MK; Dombkowski DM; Ha TU; Preffer FI; Donahoe PK
    Clin Cancer Res; 1999 Nov; 5(11):3488-99. PubMed ID: 10589763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human müllerian inhibiting substance inhibits tumor growth in vitro and in vivo.
    Chin TW; Parry RL; Donahoe PK
    Cancer Res; 1991 Apr; 51(8):2101-6. PubMed ID: 2009529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects.
    Ragin RC; Donahoe PK; Kenneally MK; Ahmad MF; MacLaughlin DT
    Protein Expr Purif; 1992 Jun; 3(3):236-45. PubMed ID: 1392620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory effects of müllerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells.
    Kim JH; Seibel MM; MacLaughlin DT; Donahoe PK; Ransil BJ; Hametz PA; Richards CJ
    J Clin Endocrinol Metab; 1992 Sep; 75(3):911-7. PubMed ID: 1517385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
    Kurian MS; de la Cuesta RS; Waneck GL; MacLaughlin DT; Manganaro TF; Donahoe PK
    Clin Cancer Res; 1995 Mar; 1(3):343-9. PubMed ID: 9815990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Müllerian inhibiting substance blocks epidermal growth factor receptor phosphorylation in fetal rat lung membranes.
    Catlin EA; Uitvlugt ND; Donahoe PK; Powell DM; Hayashi M; MacLaughlin DT
    Metabolism; 1991 Nov; 40(11):1178-84. PubMed ID: 1943746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a receptor for human müllerian inhibiting substance.
    Catlin EA; Ezzell RM; Donahoe PK; Gustafson ML; Son EV; MacLaughlin DT
    Endocrinology; 1993 Dec; 133(6):3007-13. PubMed ID: 8243329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
    Weniger JP; Cate RL; Zeis A
    J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression.
    Fallat ME; Hutson JM; Budzik GP; Donahoe PK
    Endocrinology; 1984 May; 114(5):1592-8. PubMed ID: 6143657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal antiproliferative effect of recombinant müllerian inhibiting substance on gynecological tumor cell lines and tumor explants.
    Wallen JW; Cate RL; Kiefer DM; Riemen MW; Martinez D; Hoffman RM; Donahoe PK; Von Hoff DD; Pepinsky B; Oliff A
    Cancer Res; 1989 Apr; 49(8):2005-11. PubMed ID: 2702642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.
    Pieretti-Vanmarcke R; Donahoe PK; Szotek P; Manganaro T; Lorenzen MK; Lorenzen J; Connolly DC; Halpern EF; MacLaughlin DT
    Clin Cancer Res; 2006 Mar; 12(5):1593-8. PubMed ID: 16533786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antagonistic actions of testosterone and the anti-mullerian hormone on the mullerian duct of the chick embryo in culture in vitro].
    Weniger JP; Zeis A
    Arch Anat Microsc Morphol Exp; 1982; 71(2):99-106. PubMed ID: 6897160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Müllerian inhibiting substance production and cleavage is modulated by gonadotropins and steroids.
    Kuroda T; Lee MM; Ragin RC; Hirobe S; Donahoe PK
    Endocrinology; 1991 Dec; 129(6):2985-92. PubMed ID: 1954882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific fetal lung development and müllerian inhibiting substance.
    Catlin EA; Powell SM; Manganaro TF; Hudson PL; Ragin RC; Epstein J; Donahoe PK
    Am Rev Respir Dis; 1990 Feb; 141(2):466-70. PubMed ID: 2301861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of epidermal growth factor receptor phosphorylation by activated Mullerian inhibiting substance is vanadate-sensitive.
    Maggard MA; Catlin EA; Hudson PL; Donahoe PK; MacLaughlin DT
    Metabolism; 1996 Feb; 45(2):190-5. PubMed ID: 8596488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity.
    Lorenzo HK; Teixeira J; Pahlavan N; Laurich VM; Donahoe PK; MacLaughlin DT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):89-98. PubMed ID: 11820299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Müllerian inhibiting substance].
    Shima H
    Nihon Hinyokika Gakkai Zasshi; 1993 Oct; 84(10):1747-58. PubMed ID: 8255037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.